Healthcare

 A new in-depth market analysis indicates substantial growth within the global Carrier Screening Market . Illustratively, the market was valued at approximately $1.8 billion in 2023 and is projected to reach an estimated $4.5 billion by 2033 , demonstrating a Compound Annual Growth Rate (CAGR) of approximately 9.5% from 2024 to 2033. This robust expansion is driven by increasing public awareness of genetic health, advancements in screening technologies, and the growing emphasis on proactive reproductive planning and preventative healthcare. ► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now: https://www.alliedmarketresearch.com/request-sample/A11271 Carrier screening is a crucial genetic test performed on individuals who do not show symptoms of a genetic disorder but may carry a gene mutation that could be passed on to their children. This testing is increasingly recommended for individuals or couples planning a family to assess their risk of having a child with a s...

 The “ Photomedicine Market ," size was valued at $4,047.64 million in 2020, and is estimated to reach $7.5 Billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. Photomedicine is a branch of medicine that includes the study of light and its application to treatment and diagnosis. Various medical imaging technologies, such as lasers, fluorescent lamps, and polychromatic polarized light, are used for various diagnostic and therapeutic purposes. In phototherapy, long-wavelength light is used for treatment in various fields, such as ophthalmology, dermatology, and oncology. Get Free Sample PDF of Market: https://www.alliedmarketresearch.com/request-sample/1532 Major Key Market Players - The key players operating in the global photomedicine market are Baring Private Equity Asia Limited (Lumenis Ltd.), Angiodynamics, Inc., Apax Partners LLP. (Syneron Medical Ltd.), Biomedical Technology Holdings Limited (Biolitec AG), Colorado Skin and Vein, Johnson and Johnson, Kon...

 Allied Market Research recently published a report, titled,  " Syphilis Testing Market  by By Type (Primary & Secondary Syphilis, Others), by Location of Testing (Laboratory testing, Point of care (POC) testing): Global Opportunity Analysis and Industry Forecast, 2020-2030."  According to the report, the global syphilis testing industry was pegged at $1.1 billion in 2020, and is expected to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030. Get Free Sample PDF of Market: https://www.alliedmarketresearch.com/request-sample/675 COVID-19 scenario- The outbreak of the Covid-19 pandemic negatively impacted the global syphilis testing market. This is owing to decrease in the number of patient visits to hospitals and clinics for testing, as a result of the suspension of various elective procedures and outpatient visits, which reduced the demand for syphilis tests. Between March 2019 and May 2020...